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Histone HI ’ is an H 1 subfraction w&e level on the chromatin is inversely correlated with the mitotic index 
of the cell. We ~v~~~ the incrm in HI” in 6 ceff fines when c&i division was blocked by 4 methods: 
5 mM butyratq 2% DMSQ serum withdrawal or density i~i~~~n. The 6 c&t lines (HeLa Sf and 53, CHO, 
3l’6* NE-1 15 and Veroj responded differently to the treatments a  regards the amount of increase in Hl” 
and comparisons among the fines reveal no bvious imkities between the lines in the di~e~n~al effects 
of the various treatments on H lo levels. 
Histone HI” Cell cultim Butyrate DMSO Serum withdrawal Density inhibition 
1. INTRODUCTION 
HI“ is an HI histone s&fraction that was first 
characterized by its presence in tissues with low 
mitotic indices f 1). Measurements of H1° levels 
during tissue regeneration support the idea that 
Hl’, while present in limited amounts in dividing 
cells, is greatly increased in tissues where there is 
little or no cell division [2-41. Substantial H1° 
levels seem to require both the terminal state of 
differentiation, and the concomitant non-dividing 
state [S]. In some cases IS], loss of differentiation 
of hormone-dependent tissues by hormone 
deprivation was correlated with a decrease in Hl” 
levels. The fo~o~ng question then arises. If dif- 
ferent cell types had the non-~vidin8 state in com- 
mon, and were treated with a common set of HI” 
inducers, would the cells show a common pattern 
of response? If so, a relatively simple and direct 
connection might be implied between HP levels 
and the termination of differentiation in the non- 
dividing state. 
In addition to the tissue studies mentioned 
above, Hl” has been studied in cultured cells. H1° 
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has been observed to increase in Friend [6], CHO 
[7], neuroblastoma nd HeLa [8] cells in response 
to different treatments that blocked cell division; 
in 2 cell lines blocking division was accompanied 
by recognizable diffe~ntiation. Such cell culture 
systems provide the opportunity to test for a com- 
mon pattern of response among different cell types 
exposed to the same set of HI” inducing 
treatments, and this report describes such 
experiments. 
2. MATERIALS AND METHODS 
The following cell lines and cell culture condi- 
tions were used in these studies: (A) mouse 
neurobl~toma NIE-I 15 cells and (B) African 
Green Monkey kidney (Vera) cells were grown in 
Dulbecco’s Modified Eagle’s Media supplemented 
with 10% fetal calf serum and 2 mM glutamine; 
(C) HeLa S3 cells were grown in Dulbecco’s 
Modified Eagle’s Media supplemented with 5% 
calf serum; (D) HeLa Sl cells were grown in 
Dulbecco’s Modified Eagle’s Media supplemented 
with 10% calf serum; (E) Chinese hamster ovary 
(CHO) cells were grown in F-12 supplemented with 
10% fetal calf serum and 2 mM glutamine; (F) 
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Swiss albino mouse embryo fibroblast (3T6) cells 
were grown in Dulbecco’s Modified Eagle’s Media 
supplemented with 10% calf serum, and 5 mM 
glutamine. For the inhibitor studies this medium 
was supplemented with 500 bg/ml sodium butyrate 
(5 mM) or 1 ml spectrograde DMSO per 50 ml 
culture medium (250 mM). All cells were grown in 
100 x 20 mm tissue culture dishes at 37°C in 10% 
COz. The culture media were changed every day 
for the first 4 days of each treatment, and every 
other day thereafter. To measure DNA synthesis, 
the medium was removed from the 100 x 20 mm 
tissue culture dish and the cells were washed once 
with phosphate buffered saline (10 mM phos- 
phate, 150 mM NaCI, pH 7.4). The cells were then 
incubated at 37% for 3 h in media supplemented 
with [3H]thymidine (NEN) at a concentration of 
50,&i/ml. This medium was also supplemented 
with 10pM deoxycytidine, to insure that dCTP 
was not limiting. 
2.1. Histone extraction 
Outer cell membranes were lysed by incubating 
the cells for 3 min at room temperature in 10 ml 
buffer (0.25 M sucrose, 50 mM Tris base, 25 mM 
KCI, 1 mM CaC12, 1 mM MgC12, pH 7.5) contain- 
ing 0.1% Triton X-100. The cells were washed off 
the plate in this buffer and the nuclei were pelleted 
by a 5 min centrifugation at 1000 x g and then 
resuspended in 1 ml of 0.4 N HzS04. Following an 
overnight incubation at 4”C, cell debris was 
pelleted by a 10 min centrifugation at 12000 x g 
and the histones in the supernatant were 
piecipitated by addition of trichloroacetic acid to 
20%. The precipitate was washed once with 
ethanol and air dried. 
2.2. Gel electrophoresis and analysis 
SDS-polyacrylamide gels were run according to 
the method of Laemmli [9], using a 12.5% 
acrylamide resolving gel. Gels were stained for 1 h 
in stain no.1 (0.03% Coomassie blue, 25% 
isopropanol, 10070 acetic acid) followed by 12 h in 
stain no.2 (0.0015% Coomassie blue, 5(‘1o 
isopropanol, 5% acetic acid). Gels were then de- 
stained by incubation for 24 h in 10% acetic acid. 
Gels were scanned on a Kratos SD-3000 Xenon 
lamp spectrodensitometer set at 520 nm. The out- 
put was quantified by a Hewlett-Packard 3380A 
integrator. 
3. RESULTS 
This line of research was initiated by the obser- 
vation that in the NIE-115 cell line, different 
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Fig. 1. SDS-polyacrylamide g ls showing the histone 
proteins during the time course of one treatment for 
each cell line. (A) CHO cells, butyrate treatment; (B) 
Vero cells, no serum; (C) HeLa Sl, density inhibition; 
(D) HeLa S3, no serum; (E) NIE-115 cells, butyrate 
treatment; (F) 3T6 cells, DMSO. The numbers under 
each lane represent the days of each treatment. The 
position of histone Hl“ is marked by an arrowhead on 
each gel. 
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treatments used to block cell division resulted in mouse lines were used, one of embryonic 
different increases in the level of H lo f 101 . We set fibroblast origin (3TB), the other of neural tumor 
out to determine whether this pattern was general origin (NIE-115). Finally, a monkey kidney line 
by examining several other cell fines. Four {Veroj and a hamster ovary line (CHCI) were used. 
treatments were used to block cell division. These As examples, fig. 1 shows electrophoretic patterns 
were: 5 mM butyrate; 2% DMSQ; withdrawal of of the histones sampled during the course af one 
serum and density inhibition. Six cell lines were treatment for each of the 6 cell lines. As expected 
tested, including 2 isolates of the human HeLa cell [8], the Hl histone subfractions show elec- 
line, one of which, S3, was selected on the basis of trophoretic heterogeneity among the different 
its ability to grow in suspension, while the Sl line, lines, however, in all 6 lines the levels of Hla, the 
like the other cell ines in this study, normally fastest migrating Hl species, can be observed to in- 
adheres to a plastic surface during growth. Two crease during the treatments. Hl” was identified 
Table I 
Changes in the Hl”iHlab ratio among 6 cefi Iines blocked from dividing with 4 different treatments 
Cell Treatment Day 0 n Day 4 n Day 8 n Fold 
line (HP/Hlab) (Hl*/HIab) (Hl’/Hlab) increase 
Sl 
SJ 
CHO 
3T6 
Vera 
NKE-f 15 
NaBU 
DMSO 
NS 
DI 
NaBu 
DMSO 
NS 
RI 
NaBu 
DMSO 
NS 
DI 
NaBu 
DMSO 
NS 
DI 
NaBu 
DMSO 
NS 
DI 
NaBu 
DMSO 
NS 
DI 
0.05 * 0.01 
0.13 It: 0.02 
0,08 A 0.00 
0.06 f 0.01 
0.32 f 0.03 
0.08 rdr 0,Of 
0.13 f 0.00 
0.17 + 0.02 
0.08 A 0.00 
0.16 -+ 0.02 
0.33 f 0.03 
0.33 * 0.00 
0.25 f 0.02 
0*37 f O-13 
0.86 t 0.09 
0.32 + 0.02 
0.85 + 0.20 
0.40 f 0.03 
0.21 z!z 0.03 
0.21 * 0.03 
0.21 * 0.01 
0.17 & 0.01 
0.97 r+ 0.94 
0.58 t 0.03 
0.42 -+ 0.03 
0.49 f 0.05 
0.42 + 0.04 
0.20 f 0.02 
0.19 f 0.02 
0.19 * 0.02 
3 
3 
5 
5 
5 
5 
5 
3 
5 
3 
5 
5 
5 
5 
5 
5 
4 
5 
5 
5 
5 
5 
5 
5 
0.12 f 0.01 
0.20 4 0.01 
0.10 + 0.00 
0.18 + 0.02 
0.30 f 0.07 
0.33 * 0.06 
0.23 f 0.01 
0.28 + 0.01 
0.83 f 0.12 
0.42 z!z 0.01 
0.56 f 0.16 
0.41 f 0.06 
0.23 + 0.02 
0.31 I!I 0.03 
0.20 -+ 0.02 
0.14 + 0.01 
0.89 +- 0.03 
078 +- 0.07 
0.62 -+ 0.02 
0.55 t 0.02 
0.63 f 0.06 
0.30 * 0.03 
0.29 z!I 0.03 
0.27 -+ 0.03 
4 
5 
5 
5 
5 
5 
5 
4 
5 
4 
5 
5 
5 
5 
5 
3 
5 
5 
4 
5 
5 
5 
5 
5 
3.4 
4.0 
2.0 
3.6 
2.3 
2.5 
I,8 
2.2 
IO 
5.3 
7.0 
5.1 
3,8 
5.2 
3.3 
2.3 
2.8 
2.4 
1.9 
1.7 
7.9 
3.7 
3.0 
3.4 
Treatments NaBu, 5 mM butyrate; DMSO, 2% DMSO; NS, serum withdrawal; DI, density inhibition. 
n is the number of independent plates analyzed for each value obtained. The error in measurement 
reported is the SD for each value. Fold increase refers to the factor of increase in the Day 8 vaiue 
compared with the Day 0 value for each treatment 
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with authentic bovine Hl” as the fastest moving 
Hf in acetic acid/urea gels as well as on SDS- 
containing gels. In the acetic acid/urea system, 
more extended electrophoresis showed that H1° 
could be resolved as a doublet in all lines (not 
shown), as has also been observed in the case of 
calf kidney Hl’ [ll]. 
To quantify the apparent increase in H1° during 
the treatments een in fig.1, the histones were ex- 
tracted and analyzed from multiple plates of each 
line grown for 4 or 8 days in each treatment. Using 
scanning densitomet~ of the HI histones resolved 
by SDS-polyacrylamide gel electrophoresis the 
ratio of H1° to the other HI histones was 
calculated and compared with the ratio in un- 
treated cells. The analysis is shown in table 1. The 
H l*/Hlab ratio increased with all 4 treatments in 
all 6 cell lines. However, further examination 
reveals that the amount of the increase in the 
Hl’/Hlab ratio differed among the different cell 
lines and that the relative effectiveness of the 
specific treatments on the HlO/Hlab ratio differed 
from one cell line to another. 
A comparison of the Hl“fHlab ratios before 
any treatment was begun reveals that while 4 of the 
lines (CHO, NIE-115, 3T6 and Sl) had about the 
same HlO/Hlab ratio (OS-0.8), the plated HeLa 
cells (S3) had twice the initial Hl* (0.13) of the 
spinner HeLa cells (Sl), and the Vero cells had 
4-times the starting Hl’/Hlab ratio of the first 4 
cell lines (0.32). Once treatment began, the overall 
increase in the Hl”/Hlab ratio differed substan- 
tially among the different lines with differing 
Table 2 
Ranking of Various Treatments for Induction of H1° 
Cell line Effectiveness 
Sl DMSO, DI > NaBu > NS 
s3 NaBu, DMSO, DI > NS 
3T6 NaBu, DMSO, NS > DI 
Vero NaBu > DMSO > NS, DI 
NIB NaBu > NS, DMSO, DI 
CHO NaBu, NS > DMSO, DI 
The rankings in this table were established by pooling 
the data of day 4 and 8 for each treatment listed in 
table 1. The data were then analyzed at the 99% 
confidence level by using Student’s t-test 
treatments. Butyrate treatment of CHO cells 
resulted in the most dramatic increase in the 
Hl*/Hlab ratio, a lo-fold increase over rapidly 
growing cells, while butyrate treatment of NIE-115 
cells showed the second largest increase (7.9”fold). 
However, attempts to discern general trends in 
these data have proven futile. The relative in- 
creases in Hl’/Hlab ratios were not simply a 
reflection of different extents of inhibition of 
DNA synthesis. For NIE-115 cells, after 4 days, 
butyrate, DMSO and no serum treatments howed 
identical 93% inhibitions of DNA synthesis rates 
and yet the relative effectiveness of the 3 
treatments in Hl” induction was 2.6 : 1.2 : 1, respec- 
tively. As shown in table 2, in which the treatments 
are ranked for each cell line in terms of their effect 
on the HlO/Hlab ratio based on a statistical 
analysis of the data from table 1, there are no 
generalities which can be drawn about specific 
treatments and the increase in the Hl’/Hlab ratio. 
All 6 lines have different patterns of response to 
the treatments, including the 2 HeLa lines, which 
might have been expected to be very similar in 
most respects. 
4. DISCUSSION 
The levels of Hl” were measured in 6 cell lines 
when cell division was blocked by 4 kinds of treat- 
ment. No matter what the cell type there was an in- 
crease in the Hl* ratio when cells were blocked 
from dividing. Thus, qualitatively, the correlation 
between Hl’ levels and mitotic quiescence held 
trueamong mouse, human, monkey and hamster 
cells of a variety of original tissue origins. 
However, quantitatively, the increase differed 
among the different lines from 2- to lo-fold, with 
final values of Hl*/Hlab ratios ranging between 
0.10 and 0.89. Moreover, it is striking that for a 
given cell line the amount of increase in the 
HlO/Hlab ratio was dependent on the method 
used to block the cells from dividing. Not only did 
the 4 treatments differ from each other in the ex- 
tent to which they induced H1° in any cell lines, 
but the cell lines differed in their patterns of 
response to the various treatments. For example, 
for Sl cells density inhibition was in the most ef- 
fective category and serum withdrawn in the least 
effective, while the opposite was true for CHO 
cells. The quantitative aspects of control of Hl” 
95 
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levels, therefore, are dependent upon the nature of REFERENCES 
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the inducer but they are also dependent on the dif- 
ferentiated nature of the cell. Hl” accumulation is 
not just a matter of mitotic quiescence [l] and of 
the termination of differentiation [5] but it is also 
affected by the particular pattern of differentiation 
in any cells. Clearly, then, the regulation of H1° is 
complex and the connection between an inducer 
and H1° induction is probably not direct. 
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